myeloproliferative neoplasms (MPN) | Aplastic Anemia & MDS International Foundation

myeloproliferative neoplasms (MPN)

Raoul Tibes, MD, PhD

Tibes, Raoul
Director of the Clinical Leukemia Program
NYU Hematology Associates

As a physician–scientist, Dr. Tibes is grateful for the opportunity to advance treatments for people who have cancer through my own groundbreaking research. He has been involved in developing national treatment guidelines for leukemia, and he has been actively engaged in translational research to identify and develop new leukemia treatments over the last few years. Many of these treatments, which directly target the DNA of cancer cells or push leukemia cells to die, were developed in Dr. Tibes' laboratory and have led to clinical trials and U.S. Food and Drug Administration approvals.

Imad Tabbara, MD

Tabbara, Imad
Professor of Medicine
The George Washington Cancer Center

Imad Tabbara, MD is board-certified in internal medicine, medical oncology, and hematology.  He serves as the director of the Fellowship Training Program with The George Washington University (GWU).  His career has been focused on the treatment of cancer patients, as well as, patients with benign and malignant hematologic disorders.